Hepatitis C

Hepatitis C (HCV) is a virus that is transmitted through blood, with contaminated needles being a common source of infection. Chronic infection with HCV can lead to liver cirrhosis and liver cancer.

Quick Answer

What it is

Hepatitis C (HCV) is a virus that is transmitted through blood, with contaminated needles being a common source of infection. Chronic infection with HCV can lead to liver cirrhosis and liver cancer.

Key findings

  • Grade C: Viral Load Reduction (Thymosin Alpha-1)
  • Grade C: Liver Cell Content (TUDCA)
  • Grade D: Bilirubin (Black seed)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Hepatitis C

  • Supplements Studied:6
  • Research Trials:5
  • Total Participants:661
  • Top Supplement:TUDCA (B)
5 trials
661 ppts
6 supps · 13 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

Bile acid that supports liver cell protection and reduces liver stress

6 studies | 300 participants
420mg silymarin daily (divided doses)

Hepatoprotective; antioxidant; may support liver function

10 studies | 600 participants

Supporting Stack (Tier 2)

600-1200mg daily

Glutathione precursor; antioxidant support for liver

5 studies | 200 participants
2000-4000 IU daily

Deficiency common in chronic liver disease; may affect treatment response

6 studies | 300 participants
15-30mg daily

Often deficient in liver disease; supports immune function

5 studies | 200 participants

How It Works

Hepatitis C is a viral infection that affects the liver. Thanks to modern direct-acting antiviral (DAA) medications, hepatitis C is now curable in over 95% of cases.

ABOUT HEPATITIS C:

Caused by hepatitis C virus (HCV)
Spread through blood-to-blood contact
Many people have no symptoms for years
Can lead to cirrhosis, liver cancer if untreated
Now highly curable with medications

SYMPTOMS (when present):

Fatigue
Abdominal pain
Loss of appetite
Nausea
Dark urine
Jaundice (yellow skin/eyes) - late stage

CRITICAL: Hepatitis C is now curable. See a healthcare provider for testing and treatment. This protocol is SUPPORTIVE ONLY.

MEDICAL TREATMENT:

Direct-acting antivirals (DAAs): 8-12 weeks of pills
Cure rate >95%
Examples: sofosbuvir/velpatasvir, glecaprevir/pibrentasvir
Minimal side effects compared to old interferon treatments

LIVER HEALTH SUPPORT:

Avoid alcohol completely
Maintain healthy weight
Avoid hepatotoxic medications when possible
Get vaccinated for hepatitis A and B
Regular monitoring of liver function

WHO SHOULD BE TESTED:

Everyone born 1945-1965 (baby boomer generation)
Anyone who has injected drugs
HIV-positive individuals
Blood transfusion recipients before 1992
Children of HCV-positive mothers

* TUDCA and milk thistle provide hepatoprotective support.

* NAC supports glutathione and liver detoxification.

* Correct deficiencies in vitamin D and zinc.

Expected timeline: DAA treatment cures most people in 8-12 weeks. Supplements support liver health before, during, and after treatment.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
C
Viral Load Reduction
Small Decrease
4 studies
smallImproves
C
Liver Cell Content
Small Increase
1 study
smallImproves
?
Liver Enzymes
2 studies
Worsens
D
Bilirubin
No effect
1 study
none
?
Blood glucose
1 study
Worsens
?
HCV Viral Load
1 study
Improves
?
Liver Enzymes
1 study
Worsens
?
Red Blood Cell Count
1 study
Improves
?
Serum Albumin
1 study
Improves
?
White Blood Cell Count
1 study
Improves
?
Liver Enzymes
2 studies
Worsens
?
Early Virologic Response
1 study
Improves
?
HVC Viral Load
1 study
Improves

Research Citations (100)

Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.
(2025)
PMID: 40599771
The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.
(2025)
PMID: 39814420
The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.
(2025)
PMID: 40263352
PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature review.
(2024)
PMID: 39183403
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.
(2024)
PMID: 39357524
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
(2024)
PMID: 39648386
Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials.
(2024)
PMID: 38308608
Thymosin α-1 in cancer therapy: Immunoregulation and potential applications
(2023)
PMID: 36812669
Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era
(2023)
PMID: 36871535
The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression.
(2023)
PMID: 37845598

Related Conditions

Nonalcoholic Fatty Liver Disease (NAFLD)

4 shared supplements · 221 outcomes

Non-alcoholic fatty liver disease (NAFLD) is a condition in which excessive fat (more than 5% of liver weight) accumulates in the liver due to causes unrelated to alcohol.

Metabolic Health

4 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

4 shared supplements · outcomes

Obesity

3 shared supplements · 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.

General Cancer Care and Prevention

3 shared supplements · 50 outcomes

Cancer is a group of diseases in which abnormal cells divide out of control and can invade other tissues. Cancer care and prevention refers to treatments to try to manage and cure the disease and strategies to reduce the risk of developing it.

Weight Loss & Maintenance

2 shared supplements · 433 outcomes

This goal refers to people with a BMI >25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI >25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

Type 2 Diabetes

2 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Metabolic Syndrome

2 shared supplements · 391 outcomes

Metabolic syndrome refers to a group of cardiometabolic risk factors: abdominal obesity, high blood pressure, high fasting blood sugar, high blood triglycerides, and low HDL-C. If a person has at least three of these, they have metabolic syndrome.